 |
CTD - Clinical Overview
|
 |
CTD - Analytical Overall Summary
|
 |
Necessity of in-vivo studies ("biowaiver")
|
 |
Evaluation of study findings from clinical trials of phases I and II
|
 |
Interpretation of in-vitro dissolution profiles, in-vitro/in-vivo correlations (IVIVC)
|
 |
Proposals for formulation development (dosage forms with "added value")
|
 |
Biotechnology derived medicinal products ("biosimilars" vs. "biogenerics")
|
 |
Quality of herbal medicinal products
|
Depending on the particular problem to be solved, in preparing statements we involve the specific
capacities of distinguished external experts. Whereby our excellent contacts to international opinion
leaders are indispensable.